Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen-Reference-Cited by-同舟云学术

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen

Published:2010-03 Issue:3 Volume:21 Page:498-505
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bertelli G.,Hall E.,Ireland E.,Snowdon C.F.,Jassem J.,Drosik K.,Karnicka-Mlodkowska H.,Coombes R.C.,Bliss J.M.

Funder

Pfizer Inc

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/3/498/397828/mdp358.pdf

Reference34 articles.

1. Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature;Machado;Eur J Gynaecol Oncol,2005

2. Endometrial pathologies associated with postmenopausal tamoxifen treatment;Cohen;Gynecol Oncol,2004

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005

4. Should tamoxifen users be screened for endometrial lesions?;Neven;Lancet,1998

5. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities;Smith-Bindman;JAMA,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guideline No. 451: Asymptomatic Endometrial Thickening in Postmenopausal Women;Journal of Obstetrics and Gynaecology Canada;2024-07

2. Directive clinique no 451 : Épaississement asymptomatique de l’endomètre chez les femmes ménopausées;Journal of Obstetrics and Gynaecology Canada;2024-07

3. Exogenous Hormone-Induced Endometrial Changes;Gynecologic and Obstetric Pathology;2024

4. Sonographic Changes in Endometrium after Use of Tamoxifen in Breast Cancer;Pakistan Journal of Health Sciences;2023-08-31

5. Risk factors for the development of endometrial lesions in breast cancer patients using tamoxyphen: a retrospective cohort study;Revista do Colégio Brasileiro de Cirurgiões;2023